{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:14:31Z","timestamp":1780647271114,"version":"3.54.1"},"reference-count":193,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001030","name":"Heart Foundation of Australia (","doi-asserted-by":"crossref","award":["100578)"],"award-info":[{"award-number":["100578)"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lawley Pharmaceuticals"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP1080914"],"award-info":[{"award-number":["APP1080914"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["Australian Postgraduate Award"],"award-info":[{"award-number":["Australian Postgraduate Award"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"REDiMED"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Middle-aged and older men have typically accumulated comorbidities, are increasingly sedentary, and have lower testosterone concentrations (T) compared to younger men. Reduced physical activity (PA) and lower T both are associated with, and may predispose to, metabolically adverse changes in body composition, which contribute to higher risks of cardiometabolic disease. Exercise improves cardiometabolic health, but sustained participation is problematic. By contrast, rates of T prescription have increased, particularly in middle-aged and older men without organic diseases of the hypothalamus, pituitary, or testes, reflecting the unproven concept of a restorative hormone that preserves health. Two recent large randomized trials of T, and meta-analyses of randomized trials, did not show a signal for adverse cardiovascular (CV) events, and T treatment on a background of lifestyle intervention reduced type 2 diabetes by 40% in men at high risk. Men with both higher endogenous T and higher PA levels have lower CV risk, but causality remains unproven. Exercise training interventions improve blood pressure and endothelial function in middle-aged and older men, without comparable benefits or additive effects of T treatment. Therefore, exercise training improves cardiometabolic health in middle-aged and older men when effectively applied as a supervised regimen incorporating aerobic and resistance modalities. Treatment with T may have indirect cardiometabolic benefits, mediated via favorable changes in body composition. Further evaluation of T as a pharmacological intervention to improve cardiometabolic health in aging men could consider longer treatment durations and combination with targeted exercise programs.<\/jats:p>","DOI":"10.1210\/clinem\/dgad175","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T17:56:17Z","timestamp":1679766977000},"page":"2141-2153","source":"Crossref","is-referenced-by-count":5,"title":["New Horizons: Testosterone or Exercise for Cardiometabolic Health in Older Men"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3226-2921","authenticated-orcid":false,"given":"Daniel J","family":"Green","sequence":"first","affiliation":[{"name":"School of Human Sciences (Exercise and Sport Science), The University of Western Australia , Perth, WA, 6009 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7099-9671","authenticated-orcid":false,"given":"Lauren C","family":"Chasland","sequence":"additional","affiliation":[{"name":"School of Human Sciences (Exercise and Sport Science), The University of Western Australia , Perth, WA, 6009 , Australia"},{"name":"Allied Health Department, Fiona Stanley Hospital , Perth, WA, 6150 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-912X","authenticated-orcid":false,"given":"Louise H","family":"Naylor","sequence":"additional","affiliation":[{"name":"School of Human Sciences (Exercise and Sport Science), The University of Western Australia , Perth, WA, 6009 , Australia"},{"name":"Allied Health Department, Fiona Stanley Hospital , Perth, WA, 6150 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7612-5892","authenticated-orcid":false,"given":"Bu B","family":"Yeap","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia , Perth, WA, 6009 , Australia"},{"name":"Department of Endocrinology and Diabetes, Fiona Stanley Hospital , Perth, WA, 6150 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"2023081819575317800_dgad175-B1","author":"World Health Organization","year":"2009"},{"issue":"Suppl","key":"2023081819575317800_dgad175-B2","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1097\/00005768-200106001-00016","article-title":"Physical activity and all-cause mortality: what is the dose-response relation?","volume":"33","author":"Lee","year":"2001","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"2023081819575317800_dgad175-B3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/dyq104","article-title":"Non-vigorous physical activity and all-cause mortality: systematic review and meta-analysis of cohort studies","volume":"40","author":"Woodcock","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"9798","key":"2023081819575317800_dgad175-B4","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0140-6736(11)60749-6","article-title":"Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study","volume":"378","author":"Wen","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"2023081819575317800_dgad175-B5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.annepidem.2008.09.007","article-title":"Effects of leisure and non-leisure physical activity on mortality in U","volume":"18","author":"Arrieta","year":"2008","journal-title":"Ann Epidemiol"},{"issue":"19","key":"2023081819575317800_dgad175-B6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bjsports-2019-101765","article-title":"Physical activity and mortality: what is the dose response and how big is the effect?","volume":"54","author":"Ekelund","year":"2020","journal-title":"Br J Sports Med"},{"issue":"3","key":"2023081819575317800_dgad175-B7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1113\/JP278761","article-title":"Mimicking exercise: what matters most and where to next?","volume":"599","author":"Hawley","year":"2021","journal-title":"J Physiol"},{"issue":"4","key":"2023081819575317800_dgad175-B8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5694\/mja16.00393","article-title":"Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy","volume":"205","author":"Yeap","year":"2016","journal-title":"Med J Aust"},{"issue":"5","key":"2023081819575317800_dgad175-B9","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2023081819575317800_dgad175-B10","volume-title":"Endotext","author":"Handelsman","year":"2000"},{"issue":"2","key":"2023081819575317800_dgad175-B11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmet.2007.11.003","article-title":"Fast\/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice","volume":"7","author":"Izumiya","year":"2008","journal-title":"Cell Metab"},{"issue":"8","key":"2023081819575317800_dgad175-B12","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/db09-0349","article-title":"Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice","volume":"58","author":"Tu","year":"2009","journal-title":"Diabetes"},{"issue":"1","key":"2023081819575317800_dgad175-B13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"2023081819575317800_dgad175-B14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.5694\/mja13.10111","article-title":"Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse","volume":"199","author":"Handelsman","year":"2013","journal-title":"Med J Aust"},{"issue":"7","key":"2023081819575317800_dgad175-B15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.2017.0129","article-title":"Testosterone and male aging: faltering hope for rejuvenation","volume":"317","author":"Handelsman","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"2023081819575317800_dgad175-B16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging","volume":"86","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023081819575317800_dgad175-B17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study","volume":"87","author":"Feldman","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023081819575317800_dgad175-B18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2265.2008.03372.x","article-title":"Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study","volume":"70","author":"Yeap","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023081819575317800_dgad175-B19","volume-title":"Endotext.","author":"Yeap","year":"2022"},{"issue":"11","key":"2023081819575317800_dgad175-B20","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2012-2265","article-title":"Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men","volume":"97","author":"Yeap","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023081819575317800_dgad175-B21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1530\/EJE-12-0890","article-title":"Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study","volume":"168","author":"Camacho","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2023081819575317800_dgad175-B22","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1210\/jc.2012-3842","article-title":"Longitudinal changes in testosterone over five years in community-dwelling men","volume":"98","author":"Shi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023081819575317800_dgad175-B23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/cen.12407","article-title":"Differential associations of testosterone, dihydrotestosterone and oestradiol with physical, metabolic and health-related factors in community-dwelling men aged 17-97 years from the Busselton Health Survey","volume":"81","author":"Yeap","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023081819575317800_dgad175-B24","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1210\/jc.2014-3934","article-title":"Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the Atherosclerosis Risk in Communities study","volume":"100","author":"Srinath","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023081819575317800_dgad175-B25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100409","article-title":"Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies","volume":"9","author":"Brand","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"2023081819575317800_dgad175-B26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"295","author":"Ding","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"2023081819575317800_dgad175-B27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ecl.2021.11.004","article-title":"Testosterone, diabetes risk, and diabetes prevention in men","volume":"51","author":"Yeap","year":"2022","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"17","key":"2023081819575317800_dgad175-B28","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1161\/01.CIR.0000125854.51637.06","article-title":"Endogenous sex hormones and progression of carotid atherosclerosis in elderly men","volume":"109","author":"Muller","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"2023081819575317800_dgad175-B29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10654-009-9322-2","article-title":"Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Troms\u00f8 study","volume":"24","author":"Vikan","year":"2009","journal-title":"Eur J Epidemiol"},{"issue":"16","key":"2023081819575317800_dgad175-B30","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2011.07.019","article-title":"High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden","volume":"58","author":"Ohlsson","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2023081819575317800_dgad175-B31","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/jc.2008-2416","article-title":"Lower testosterone levels predict incident stroke and transient ischemic attack in older men","volume":"94","author":"Yeap","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2023081819575317800_dgad175-B32","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2014-2664","article-title":"In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but not myocardial infarction","volume":"99","author":"Yeap","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023081819575317800_dgad175-B33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7326\/M21-0551","article-title":"Associations of serum testosterone and sex hormone-binding globulin with incident cardiovascular events in middle-aged to older men","volume":"175","author":"Yeap","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"2023081819575317800_dgad175-B34","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1210\/jc.2013-3272","article-title":"In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality","volume":"99","author":"Yeap","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023081819575317800_dgad175-B35","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1210\/jc.2008-2650","article-title":"Low serum testosterone and estradiol predict mortality in elderly men","volume":"94","author":"Tivesten","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023081819575317800_dgad175-B36","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2013-2052","article-title":"Late-onset hypogonadism and mortality in aging men","volume":"99","author":"Pye","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"2023081819575317800_dgad175-B37","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.107.719005","article-title":"Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study","volume":"116","author":"Khaw","year":"2007","journal-title":"Circulation"},{"issue":"11","key":"2023081819575317800_dgad175-B38","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.amjcard.2019.02.042","article-title":"Cardiovascular outcomes and all-cause mortality following measurement of endogenous testosterone levels","volume":"123","author":"Adelborg","year":"2019","journal-title":"Am J Cardiol"},{"issue":"4","key":"2023081819575317800_dgad175-B39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/cen.13089","article-title":"Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17-97 years","volume":"85","author":"Chan","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2023081819575317800_dgad175-B40","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1210\/jc.2013-3576","article-title":"Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the Cardiovascular Health Study","volume":"99","author":"Shores","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023081819575317800_dgad175-B41","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1210\/clinem\/dgaa743","article-title":"Serum testosterone is inversely and sex hormone-binding globulin is directly associated with all-cause mortality in men","volume":"106","author":"Yeap","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023081819575317800_dgad175-B42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"2023081819575317800_dgad175-B43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1210\/jc.2009-1251","article-title":"Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study","volume":"95","author":"Srinivas-Shankar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023081819575317800_dgad175-B44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2023081819575317800_dgad175-B45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons from the Testosterone Trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"issue":"7","key":"2023081819575317800_dgad175-B46","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"2023081819575317800_dgad175-B47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2213-8587(17)30416-3","article-title":"Testosterone treatment in older men: clinical implications and unresolved questions from the Testosterone Trials","volume":"6","author":"Yeap","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2023081819575317800_dgad175-B48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2015.8881","article-title":"Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: a randomized clinical trial","volume":"314","author":"Basaria","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"2023081819575317800_dgad175-B49","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/dom.13601","article-title":"Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): design and implementation of a double-blind randomized controlled trial","volume":"21","author":"Wittert","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2023081819575317800_dgad175-B50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2023081819575317800_dgad175-B51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/jc.2017-02243","article-title":"The effect of testosterone on cardiovascular biomarkers in the testosterone trials","volume":"103","author":"Mohler","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023081819575317800_dgad175-B52","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","article-title":"Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study)","volume":"34","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"issue":"10","key":"2023081819575317800_dgad175-B53","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2008-04-154112","article-title":"Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c","volume":"112","author":"Cohen","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2023081819575317800_dgad175-B54","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1042\/bj20020325","article-title":"Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes","volume":"365","author":"Delpierre","year":"2002","journal-title":"Biochem J"},{"issue":"9","key":"2023081819575317800_dgad175-B55","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2337\/diabetes.50.9.2139","article-title":"Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo","volume":"50","author":"Szwergold","year":"2001","journal-title":"Diabetes"},{"issue":"1","key":"2023081819575317800_dgad175-B56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-11-108","article-title":"Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med"},{"issue":"6","key":"2023081819575317800_dgad175-B57","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jsxm.2018.04.641","article-title":"Testosterone and cardiovascular risk: meta-analysis of interventional studies","volume":"15","author":"Corona","year":"2018","journal-title":"J Sex Med"},{"issue":"6","key":"2023081819575317800_dgad175-B58","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1016\/S2666-7568(22)00096-4","article-title":"Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis","volume":"3","author":"Hudson","year":"2022","journal-title":"Lancet Healthy Longev"},{"issue":"11","key":"2023081819575317800_dgad175-B59","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"2023081819575317800_dgad175-B60","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1517\/14740338.2014.950653","article-title":"Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis","volume":"13","author":"Corona","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"2023081819575317800_dgad175-B61","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015284","article-title":"Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis","volume":"7","author":"Elliott","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"2023081819575317800_dgad175-B62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjmed.2016.09.017","article-title":"Cardiovascular risks of exogenous testosterone use among men: a systematic review and meta-analysis","volume":"130","author":"Alexander","year":"2017","journal-title":"Am J Med"},{"issue":"2","key":"2023081819575317800_dgad175-B63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/M19-0830","article-title":"Efficacy and safety of testosterone treatment in men: an evidence report for a clinical practice guideline by the American College of Physicians","volume":"172","author":"Diem","year":"2020","journal-title":"Ann Intern Med"},{"issue":"2","key":"2023081819575317800_dgad175-B64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/aja.aja_25_17","article-title":"Testosterone treatment and cardiovascular events in prescription database studies","volume":"20","author":"Shores","year":"2018","journal-title":"Asian J Androl"},{"issue":"6","key":"2023081819575317800_dgad175-B65","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2011-2591","article-title":"Testosterone treatment and mortality in men with low testosterone levels","volume":"97","author":"Shores","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"2023081819575317800_dgad175-B66","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"2023081819575317800_dgad175-B67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"issue":"40","key":"2023081819575317800_dgad175-B68","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehv346","article-title":"Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men","volume":"36","author":"Sharma","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"2023081819575317800_dgad175-B69","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.amjcard.2015.11.063","article-title":"Impact of testosterone replacement therapy on myocardial infarction, stroke, and death in men with low testosterone concentrations in an integrated health care system","volume":"117","author":"Anderson","year":"2016","journal-title":"Am J Cardiol"},{"issue":"6","key":"2023081819575317800_dgad175-B70","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","volume":"4","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2023081819575317800_dgad175-B71","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jamainternmed.2016.9546","article-title":"Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency","volume":"177","author":"Cheetham","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"6","key":"2023081819575317800_dgad175-B72","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2023081819575317800_dgad175-B73","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.amjmed.2019.03.022","article-title":"Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study","volume":"132","author":"Loo","year":"2019","journal-title":"Am J Med"},{"issue":"8","key":"2023081819575317800_dgad175-B74","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.amjcard.2019.07.019","article-title":"Relation of testosterone normalization to mortality and myocardial infarction in men with previous myocardial infarction","volume":"124","author":"Oni","year":"2019","journal-title":"Am J Cardiol"},{"issue":"17","key":"2023081819575317800_dgad175-B75","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020562","article-title":"Association between testosterone treatment and risk of incident cardiovascular events among US male veterans with low testosterone levels and multiple medical comorbidities","volume":"10","author":"Shores","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"2023081819575317800_dgad175-B76","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1210\/jc.2018-00404","article-title":"The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials","volume":"103","author":"Ponce","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023081819575317800_dgad175-B77","doi-asserted-by":"crossref","first-page":"228-2","DOI":"10.5694\/mja16.00448","article-title":"Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations","volume":"205","author":"Yeap","year":"2016","journal-title":"Med J Aust"},{"key":"2023081819575317800_dgad175-B78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ahj.2021.11.016","article-title":"Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: rationale and design of the TRAVERSE study","volume":"245","author":"Bhasin","year":"2022","journal-title":"Am Heart J"},{"key":"2023081819575317800_dgad175-B79","author":"US National Library of Medicine"},{"issue":"4","key":"2023081819575317800_dgad175-B80","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ije\/26.4.739","article-title":"Association of leisure time physical activity with the risk of coronary heart disease, hypertension and diabetes in middle-aged men and women","volume":"26","author":"Haapanen","year":"1997","journal-title":"Int J Epidemiol"},{"key":"2023081819575317800_dgad175-B81","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12877-015-0157-2","article-title":"Physical activity and vascular disease in a prospective cohort study of older men: the Health In Men study (HIMS)","volume":"15","author":"Lacey","year":"2015","journal-title":"BMC Geriatr"},{"issue":"9","key":"2023081819575317800_dgad175-B82","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/STROKEAHA.113.001538","article-title":"Physical activity frequency and risk of incident stroke in a national US study of blacks and whites","volume":"44","author":"McDonnell","year":"2013","journal-title":"Stroke"},{"issue":"1","key":"2023081819575317800_dgad175-B83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003487","article-title":"Accelerometer measured physical activity and the incidence of cardiovascular disease: evidence from the UK Biobank cohort study","volume":"18","author":"Ramakrishnan","year":"2021","journal-title":"PLoS Med"},{"issue":"3","key":"2023081819575317800_dgad175-B84","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjsports-2013-092814","article-title":"150 Minutes of vigorous physical activity per week predicts survival and successful ageing: a population-based 11-year longitudinal study of 12 201 older Australian men","volume":"48","author":"Almeida","year":"2014","journal-title":"Br J Sports Med"},{"issue":"11","key":"2023081819575317800_dgad175-B85","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10654-014-9963-7","article-title":"Leisure time physical activity and long-term cardiovascular and cancer outcomes: the Busselton Health Study","volume":"29","author":"Gunnell","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"2023081819575317800_dgad175-B86","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/jgs.15542","article-title":"Physical activity and association between frailty and all-cause and cardiovascular mortality in older adults: population-based prospective cohort study","volume":"66","author":"Higueras-Fresnillo","year":"2018","journal-title":"J Am Geriatr Soc"},{"issue":"10113","key":"2023081819575317800_dgad175-B87","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/S0140-6736(17)31634-3","article-title":"The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study","volume":"390","author":"Lear","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"2023081819575317800_dgad175-B88","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM198603063141003","article-title":"Physical activity, all-cause mortality, and longevity of college alumni","volume":"314","author":"Paffenbarger","year":"1986","journal-title":"N Engl J Med"},{"issue":"10","key":"2023081819575317800_dgad175-B89","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2105\/AJPH.52.10.1697","article-title":"Death rates among physically active and sedentary employees of the railroad industry","volume":"52","author":"Taylor","year":"1962","journal-title":"Am J Public Health Nations Health"},{"issue":"7463","key":"2023081819575317800_dgad175-B90","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(66)93034-0","article-title":"Incidence and prediction of ischaemic heart-disease in London busmen","volume":"288","author":"Morris","year":"1966","journal-title":"Lancet"},{"issue":"3","key":"2023081819575317800_dgad175-B91","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.aje.a112608","article-title":"Physical activity as an index of heart attack risk in college alumni","volume":"108","author":"Paffenbarger","year":"1978","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2023081819575317800_dgad175-B92","doi-asserted-by":"crossref","first-page":"E386","DOI":"10.1016\/S2468-2667(21)00032-3","article-title":"Occupational physical activity and longevity in working men and women in Norway: a prospective cohort study","volume":"6","author":"Dalene","year":"2021","journal-title":"Lancet Public Health"},{"issue":"23","key":"2023081819575317800_dgad175-B93","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1001\/jama.2014.5616","article-title":"Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial","volume":"311","author":"Pahor","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"2023081819575317800_dgad175-B94","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cen.14342","article-title":"Sociodemographic, lifestyle and medical influences on serum testosterone and sex hormone-binding globulin in men from UK Biobank","volume":"94","author":"Yeap","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2023081819575317800_dgad175-B95","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/cen.13407","article-title":"Greater physical activity and higher androgen concentrations are independently associated with lower cardiometabolic risk in men","volume":"87","author":"Chasland","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2023081819575317800_dgad175-B96","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/cen.13905","article-title":"Higher circulating androgens and higher physical activity levels are associated with less central adiposity and lower risk of cardiovascular death in older men","volume":"90","author":"Chasland","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023081819575317800_dgad175-B97","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cen.14442","article-title":"Effects of testosterone treatment, with and without exercise training, on ambulatory blood pressure in middle-aged and older men","volume":"95","author":"Chasland","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2023081819575317800_dgad175-B98","doi-asserted-by":"crossref","first-page":"H1985","DOI":"10.1152\/ajpheart.00010.2021","article-title":"Testosterone and exercise: effects on fitness, body composition, and strength in middle-to-older aged men with low-normal serum testosterone levels","volume":"320","author":"Chasland","year":"2021","journal-title":"Am J Physiol Heart Circ"},{"issue":"4","key":"2023081819575317800_dgad175-B99","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/HYPERTENSIONAHA.120.16411","article-title":"Testosterone and exercise in middle-to-older aged men: combined and independent effects on vascular function","volume":"77","author":"Chasland","year":"2021","journal-title":"Hypertension"},{"issue":"9","key":"2023081819575317800_dgad175-B100","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart Disease and Stroke Statistics\u20142020 Update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"9455","key":"2023081819575317800_dgad175-B101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"issue":"9349","key":"2023081819575317800_dgad175-B102","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"7","key":"2023081819575317800_dgad175-B103","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019559","article-title":"Association of serum testosterone and luteinizing hormone with blood pressure and risk of cardiovascular disease in middle-aged and elderly men","volume":"10","author":"Qu","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2023081819575317800_dgad175-B104","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/EJE-07-0893","article-title":"Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health In Men Study","volume":"158","author":"Chubb","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2023081819575317800_dgad175-B105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/13685538.2016.1154523","article-title":"Total testosterone levels are correlated to metabolic syndrome components","volume":"19","author":"Blaya","year":"2016","journal-title":"Aging Male"},{"issue":"6","key":"2023081819575317800_dgad175-B106","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2008-2338","article-title":"Testosterone and growth hormone improve body composition and muscle performance in older men","volume":"94","author":"Sattler","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023081819575317800_dgad175-B107","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/gerona\/58.7.M618","article-title":"Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status","volume":"58","author":"Wittert","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"18","key":"2023081819575317800_dgad175-B108","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1001\/jama.288.18.2282","article-title":"Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial","volume":"288","author":"Blackman","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"2023081819575317800_dgad175-B109","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1210\/jcem.82.6.3988","article-title":"Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial","volume":"82","author":"Sih","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023081819575317800_dgad175-B110","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1210\/jc.2007-0620","article-title":"Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men","volume":"92","author":"Zitzmann","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023081819575317800_dgad175-B111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","article-title":"Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"82","author":"Haddad","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2023081819575317800_dgad175-B112","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","article-title":"Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. The Dublin Outcome Study","volume":"46","author":"Dolan","year":"200","journal-title":"Hypertension"},{"issue":"8","key":"2023081819575317800_dgad175-B113","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/HJH.0b013e3281c49da5","article-title":"Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals","volume":"25","author":"Hansen","year":"2007","journal-title":"J Hypertens"},{"issue":"3","key":"2023081819575317800_dgad175-B114","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/HYPERTENSIONAHA.121.17308","article-title":"Office, central, and ambulatory blood pressure for predicting first stroke in older adults: a community-based cohort study","volume":"78","author":"Matsumoto","year":"2021","journal-title":"Hypertension"},{"issue":"5","key":"2023081819575317800_dgad175-B115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2019.9811","article-title":"Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes","volume":"322","author":"Yang","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"2023081819575317800_dgad175-B116","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.HYP.24.6.793","article-title":"Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension","volume":"24","author":"Verdecchia","year":"1994","journal-title":"Hypertension"},{"issue":"6","key":"2023081819575317800_dgad175-B117","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/jhh.2013.124","article-title":"Chronic distress and acute vascular stress responses associated with ambulatory blood pressure in low-testosterone African men: the SABPA Study","volume":"28","author":"Malan","year":"2014","journal-title":"J Hum Hypertens"},{"issue":"11","key":"2023081819575317800_dgad175-B118","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1097\/HJH.0000000000001812","article-title":"Association between sex hormones and ambulatory blood pressure","volume":"36","author":"Jim\u00e9nez","year":"2018","journal-title":"J Hypertens"},{"issue":"11","key":"2023081819575317800_dgad175-B119","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jsxm.2019.08.013","article-title":"Safety of a new subcutaneous testosterone enanthate auto-injector: results of a 26-week study","volume":"16","author":"Gittelman","year":"2019","journal-title":"J Sex Med"},{"issue":"8","key":"2023081819575317800_dgad175-B120","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1210\/clinem\/dgaa238","article-title":"A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men","volume":"105","author":"Swerdloff","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023081819575317800_dgad175-B121","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/10742484211027394","article-title":"Effects of a novel oral testosterone undecanoate on ambulatory blood pressure in hypogonadal men","volume":"26","author":"White","year":"2021","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"7","key":"2023081819575317800_dgad175-B122","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/jch.14297","article-title":"Effects of the oral testosterone undecanoate Kyzatrex\u2122 on ambulatory blood pressure in hypogonadal men","volume":"23","author":"White","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"2023081819575317800_dgad175-B123","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.HYP.0000184225.05629.51","article-title":"Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors","volume":"46","author":"Cornelissen","year":"2005","journal-title":"Hypertension"},{"issue":"2","key":"2023081819575317800_dgad175-B124","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004872-200502000-00003","article-title":"Effect of resistance training on resting blood pressure: a meta-analysis of randomized controlled trials","volume":"23","author":"Cornelissen","year":"2005","journal-title":"J Hypertens"},{"issue":"4","key":"2023081819575317800_dgad175-B125","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/HJH.0b013e32835ca964","article-title":"Endurance exercise beneficially affects ambulatory blood pressure: a systematic review and meta-analysis","volume":"31","author":"Cornelissen","year":"2013","journal-title":"J Hypertens"},{"issue":"7","key":"2023081819575317800_dgad175-B126","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-136-7-200204020-00006","article-title":"Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials","volume":"136","author":"Whelton","year":"2002","journal-title":"Ann Intern Med"},{"issue":"3","key":"2023081819575317800_dgad175-B127","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1249\/01.MSS.0000115224.88514.3A","article-title":"American College of Sports Medicine position stand. Exercise and hypertension","volume":"36","author":"Pescatello","year":"2004","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"2023081819575317800_dgad175-B128","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.004473","article-title":"Exercise training for blood pressure: a systematic review and meta-analysis","volume":"2","author":"Cornelissen","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2023081819575317800_dgad175-B129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/oxfordjournals.aje.a113537","article-title":"Physical activity and incidence of hypertension in college alumni","volume":"117","author":"Paffenbarger","year":"1983","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2023081819575317800_dgad175-B130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jama.1984.03350040017014","article-title":"Physical fitness and incidence of hypertension in healthy normotensive men and women","volume":"252","author":"Blair","year":"1984","journal-title":"JAMA"},{"issue":"11","key":"2023081819575317800_dgad175-B131","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11906-015-0600-y","article-title":"Exercise for hypertension: a prescription update integrating existing recommendations with emerging research","volume":"17","author":"Pescatello","year":"2015","journal-title":"Curr Hypertens Rep"},{"issue":"14","key":"2023081819575317800_dgad175-B132","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/bjsports-2018-099921","article-title":"How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure","volume":"53","author":"Naci","year":"2019","journal-title":"Br J Sports Med"},{"issue":"6","key":"2023081819575317800_dgad175-B133","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1161\/01.CIR.90.6.2870","article-title":"Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study","volume":"90","author":"Palatini","year":"1994","journal-title":"Circulation"},{"issue":"3","key":"2023081819575317800_dgad175-B134","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.amjhyper.2005.07.021","article-title":"Exercise capacity and 24-h blood pressure in prehypertensive men and women","volume":"19","author":"Kokkinos","year":"2006","journal-title":"Am J Hypertens"},{"issue":"6","key":"2023081819575317800_dgad175-B135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.6061\/clinics\/2017(06)06","article-title":"Combined aerobic and resistance training: are there additional benefits for older hypertensive adults?","volume":"72","author":"Lima","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"issue":"24","key":"2023081819575317800_dgad175-B136","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018487","article-title":"Exercise reduces ambulatory blood pressure in patients with hypertension: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Saco-Ledo","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2023081819575317800_dgad175-B137","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijcard.2014.01.100","article-title":"Heated water-based exercise training reduces 24-hour ambulatory blood pressure levels in resistant hypertensive patients: a randomized controlled trial (HEx trial)","volume":"172","author":"Guimar\u00e3es","year":"2014","journal-title":"Int J Cardiol"},{"issue":"6","key":"2023081819575317800_dgad175-B138","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/hr.2010.42","article-title":"Effects of continuous vs. interval exercise training on blood pressure and arterial stiffness in treated hypertension","volume":"33","author":"Guimar\u00e3es","year":"2010","journal-title":"Hypertens Res"},{"issue":"6","key":"2023081819575317800_dgad175-B139","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2164\/jandrol.108.007005","article-title":"Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone","volume":"30","author":"Heufelder","year":"2009","journal-title":"J Androl"},{"issue":"4","key":"2023081819575317800_dgad175-B140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1440-2440(99)80007-3","article-title":"Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study","volume":"2","author":"Giorgi","year":"1999","journal-title":"J Sci Med Sport"},{"issue":"6","key":"2023081819575317800_dgad175-B141","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1152\/japplphysiol.00165.2018","article-title":"Effects of testosterone and progressive resistance exercise on vascular function in older men","volume":"125","author":"Hildreth","year":"2018","journal-title":"J Appl Physiol (1985)"},{"key":"2023081819575317800_dgad175-B142","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ebiom.2019.07.059","article-title":"Effects of testosterone supplementation on body composition and lower-body muscle function during severe exercise- and diet-induced energy deficit: a proof-of-concept, single centre, randomised, double-blind, controlled trial","volume":"46","author":"Pasiakos","year":"2019","journal-title":"EBioMedicine"},{"issue":"3","key":"2023081819575317800_dgad175-B143","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/HJH.0000000000001914","article-title":"Different effects of antihypertensive treatment on office and ambulatory blood pressure: a meta-analysis","volume":"37","author":"Soranna","year":"2019","journal-title":"J Hypertens"},{"issue":"11","key":"2023081819575317800_dgad175-B144","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00004872-200211000-00017","article-title":"Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study","volume":"20","author":"Ohkubo","year":"2002","journal-title":"J Hypertens"},{"issue":"22","key":"2023081819575317800_dgad175-B145","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1161\/hc4601.099485","article-title":"Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease","volume":"104","author":"Heitzer","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"2023081819575317800_dgad175-B146","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/HYPERTENSIONAHA.113.02044","article-title":"Is flow-mediated dilation nitric oxide mediated? A meta-analysis","volume":"63","author":"Green","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"2023081819575317800_dgad175-B147","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijcard.2012.09.047","article-title":"Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis","volume":"168","author":"Ras","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"2023081819575317800_dgad175-B148","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.110.167015","article-title":"Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?","volume":"57","author":"Green","year":"2011","journal-title":"Hypertension"},{"issue":"6","key":"2023081819575317800_dgad175-B149","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10554-010-9616-1","article-title":"Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis","volume":"26","author":"Inaba","year":"2010","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"2023081819575317800_dgad175-B150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0735-1097(94)90305-0","article-title":"Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women","volume":"24","author":"Celermajer","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2023081819575317800_dgad175-B151","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/ATVBAHA.111.232876","article-title":"Association of testosterone levels with endothelial function in men: results from a population-based study","volume":"32","author":"Empen","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2023081819575317800_dgad175-B152","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1291\/hypres.30.1029","article-title":"Low testosterone level is an independent determinant of endothelial dysfunction in men","volume":"30","author":"Akishita","year":"2007","journal-title":"Hypertens Res"},{"issue":"4","key":"2023081819575317800_dgad175-B153","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/13685538.2011.593655","article-title":"Endogenous testosterone and brachial artery endothelial function in middle-aged men with symptoms of late-onset hypogonadism","volume":"14","author":"M\u00e4kinen","year":"2011","journal-title":"Aging Male"},{"issue":"3","key":"2023081819575317800_dgad175-B154","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40618-015-0325-4","article-title":"Acute endothelial response to testosterone gel administration in men with severe hypogonadism and its relationship to androgen receptor polymorphism: a pilot study","volume":"39","author":"Francomano","year":"2016","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2023081819575317800_dgad175-B155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9149(99)00630-X","article-title":"Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease","volume":"85","author":"Ong","year":"2000","journal-title":"Am J Cardiol"},{"issue":"3","key":"2023081819575317800_dgad175-B156","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13685538.2018.1468429","article-title":"The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes","volume":"21","author":"Groti","year":"2018","journal-title":"Aging Male"},{"issue":"4","key":"2023081819575317800_dgad175-B157","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40618-014-0066-9","article-title":"Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study","volume":"37","author":"Francomano","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2023081819575317800_dgad175-B158","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2265.2003.01796.x","article-title":"Physiological testosterone replacement and arterial endothelial function in men","volume":"59","author":"Sader","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2023081819575317800_dgad175-B159","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1210\/jc.2005-1398","article-title":"Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy","volume":"91","author":"Bernini","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023081819575317800_dgad175-B160","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1210\/jc.2002-020504","article-title":"Vascular reactivity in hypogonadal men is reduced by androgen substitution","volume":"87","author":"Zitzmann","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023081819575317800_dgad175-B161","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.amjcard.2007.09.114","article-title":"Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease","volume":"101","author":"Webb","year":"2008","journal-title":"Am J Cardiol"},{"issue":"4","key":"2023081819575317800_dgad175-B162","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41443-019-0163-6","article-title":"Effect of treatment with testosterone on endothelial function in hypogonadal men: a systematic review and meta-analysis","volume":"32","author":"Sansone","year":"2020","journal-title":"Int J Impot Res"},{"issue":"30","key":"2023081819575317800_dgad175-B163","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","article-title":"Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans","volume":"40","author":"Thijssen","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"2023081819575317800_dgad175-B164","doi-asserted-by":"crossref","first-page":"H2","DOI":"10.1152\/ajpheart.00471.2010","article-title":"Assessment of flow-mediated dilation in humans: a methodological and physiological guideline","volume":"300","author":"Thijssen","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"2023081819575317800_dgad175-B165","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.91.4.1154","article-title":"Testosterone relaxes rabbit coronary arteries and aorta","volume":"91","author":"Yue","year":"1995","journal-title":"Circulation"},{"issue":"10","key":"2023081819575317800_dgad175-B166","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.CIR.94.10.2614","article-title":"Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo","volume":"94","author":"Chou","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"2023081819575317800_dgad175-B167","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/cs0990077","article-title":"Aging reduces the responsiveness of coronary arteries from male Wistar rats to the vasodilatory action of testosterone","volume":"99","author":"English","year":"2000","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"2023081819575317800_dgad175-B168","doi-asserted-by":"crossref","first-page":"H1720","DOI":"10.1152\/ajpheart.2001.281.4.H1720","article-title":"Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel","volume":"281","author":"Deenadayalu","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8875","key":"2023081819575317800_dgad175-B169","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0140-6736(93)92720-E","article-title":"Anabolic steroids and vascular responses","volume":"342","author":"Green","year":"1993","journal-title":"Lancet"},{"issue":"7","key":"2023081819575317800_dgad175-B170","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9149(02)02202-6","article-title":"Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease","volume":"89","author":"Kang","year":"2002","journal-title":"Am J Cardiol"},{"issue":"16","key":"2023081819575317800_dgad175-B171","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/01.CIR.102.16.1906","article-title":"Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study","volume":"102","author":"English","year":"2000","journal-title":"Circulation"},{"issue":"16","key":"2023081819575317800_dgad175-B172","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.100.16.1690","article-title":"Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease","volume":"100","author":"Webb","year":"1999","journal-title":"Circulation"},{"issue":"13","key":"2023081819575317800_dgad175-B173","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.99.13.1666","article-title":"Acute anti-ischemic effect of testosterone in men with coronary artery disease","volume":"99","author":"Rosano","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"2023081819575317800_dgad175-B174","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00014.2016","article-title":"Vascular adaptation to exercise in humans: role of hemodynamic stimuli","volume":"97","author":"Green","year":"2017","journal-title":"Physiol Rev"},{"issue":"1","key":"2023081819575317800_dgad175-B175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2004.068197","article-title":"Effect of exercise training on endothelium-derived nitric oxide function in humans","volume":"561","author":"Green","year":"2004","journal-title":"J Physiol"},{"issue":"4","key":"2023081819575317800_dgad175-B176","doi-asserted-by":"crossref","first-page":"H1999","DOI":"10.1152\/ajpheart.2000.279.4.H1999","article-title":"Effect of aerobic and resistance exercise training on vascular function in heart failure","volume":"279","author":"Maiorana","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"2023081819575317800_dgad175-B177","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0735-1097(01)01439-5","article-title":"The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes","volume":"38","author":"Maiorana","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2023081819575317800_dgad175-B178","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1097\/00005768-200112000-00008","article-title":"Exercise training, vascular function, and functional capacity in middle-aged subjects","volume":"33","author":"Maiorana","year":"2001","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"2023081819575317800_dgad175-B179","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1152\/japplphysiol.00012.2003","article-title":"Exercise training improves conduit vessel function in patients with coronary artery disease","volume":"95","author":"Walsh","year":"2003","journal-title":"J Appl Physiol (1985)"},{"issue":"18","key":"2023081819575317800_dgad175-B180","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0195-668X(03)00384-1","article-title":"Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects","volume":"24","author":"Walsh","year":"2003","journal-title":"Eur Heart J"},{"issue":"9","key":"2023081819575317800_dgad175-B181","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1249\/MSS.0000000000002654","article-title":"Adaptation to exercise training in conduit arteries and cutaneous microvessels in humans: an optical coherence tomography study","volume":"53","author":"Argarini","year":"2021","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"2023081819575317800_dgad175-B182","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1113\/jphysiol.2012.247387","article-title":"A prospective randomized longitudinal study involving 6 months of endurance or resistance exercise","volume":"591","author":"Spence","year":"2013","journal-title":"J Physiol"},{"issue":"8","key":"2023081819575317800_dgad175-B183","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201449","article-title":"Exercise training improves vascular function and secondary health measures in survivors of pediatric oncology related cerebral insult","volume":"13","author":"Long","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"2023081819575317800_dgad175-B184","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40279-014-0272-9","article-title":"Exercise modalities and endothelial function: a systematic review and dose-response meta-analysis of randomized controlled trials","volume":"45","author":"Ashor","year":"2015","journal-title":"Sports Med"},{"key":"2023081819575317800_dgad175-B185","article-title":"Evaluation of the EndoPAT as a tool to assess endothelial function","volume":"2012","author":"Moerland","year":"2012","journal-title":"Int J Vasc Med"},{"key":"2023081819575317800_dgad175-B186","article-title":"A comparison of measures of endothelial function in patients with peripheral arterial disease and age and gender matched controls","volume":"2016","author":"Allan","year":"2016","journal-title":"Int J Vasc Med"},{"issue":"2","key":"2023081819575317800_dgad175-B187","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1358863X12436708","article-title":"Reproducibility of different methods to measure the endothelial function","volume":"17","author":"Onkelinx","year":"2012","journal-title":"Vasc Med"},{"issue":"3","key":"2023081819575317800_dgad175-B188","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejvs.2012.12.002","article-title":"A comparison of flow-mediated dilatation and peripheral artery tonometry for measurement of endothelial function in healthy individuals and patients with peripheral arterial disease","volume":"45","author":"Allan","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"2023081819575317800_dgad175-B189","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2012-3695","article-title":"Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels","volume":"98","author":"Hildreth","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023081819575317800_dgad175-B190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1358863x07086671","article-title":"Characterization of the brachial artery shear stress following walking exercise","volume":"13","author":"Padilla","year":"2008","journal-title":"Vasc Med"},{"issue":"3","key":"2023081819575317800_dgad175-B191","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1249\/MSS.0000000000001448","article-title":"Associations of muscle mass and strength with all-cause mortality among US older adults","volume":"50","author":"Li","year":"2018","journal-title":"Med Sci Sports Exerc"},{"issue":"11","key":"2023081819575317800_dgad175-B192","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa011858","article-title":"Exercise capacity and mortality among men referred for exercise testing","volume":"346","author":"Myers","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"2023081819575317800_dgad175-B193","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/ehjci\/jet256","article-title":"Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis","volume":"15","author":"Xu","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad175\/49851548\/dgad175.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/9\/2141\/51172237\/dgad175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/9\/2141\/51172237\/dgad175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:53:53Z","timestamp":1729126433000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/9\/2141\/7086078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":193,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,3,25]]},"published-print":{"date-parts":[[2023,8,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad175","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,3,25]]}}}